Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting
PM&R · 13.04.2026
DOI: 10.1002/pmrj.70135 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 13.04.2026. Verfasst von Caitlin Cassidy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Academic Medical Organization of Southwestern Ontario.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Background
Adolescents and adults with cerebral palsy often experience multimorbidity related to their condition, which primarily affects movement and posture but is also associated with pain, epilepsy, mood disorders, and other conditions. As such, these patients are often prescribed a range of medications to manage symptoms, thereby putting them at risk for polypharmacy.
Objectives
To determine the proportion of adolescent and adult patients with cerebral palsy experiencing polypharmacy in a clinical setting and to identify patient factors associated with polypharmacy. Design and Setting This cross‐sectional study involved a retrospective review of medical records from initial visits at the Transitional and Lifelong Care (TLC) program, a specialized outpatient service for adolescents and adults with childhood onset disabilities at a rehabilitation hospital in London, Ontario, Canada.
Participants
All patients with a formal diagnosis of cerebral palsy who had an initial visit with the TLC program between October 2014 and December 2017 ( n = 307).
Interventions
Not applicable. Main Outcome Measures Based on the number of regularly scheduled medications recorded, patients taking ≥5 medications were identified as experiencing polypharmacy.
Results
Within the sample of 304 patients, 101 (33.2%) were experiencing polypharmacy (average: 7.9 ± 2.9 medications). Modified Poisson regression models were used to estimate the adjusted prevalence ratios (aPR) and 95% confidence intervals (CIs) for the association between patient factors and polypharmacy. Older age (aPR: 2.12; 95% CI: 1.19–3.77), higher Gross Motor Function Classification System (GMFCS) level (aPR: 1.59; 95% CI: 1.02–2.48), and epilepsy history (aPR: 1.64; 95% CI: 1.13–2.38) were associated with experiencing polypharmacy.
Conclusion
Polypharmacy is a common phenomenon among adolescent and adult patients with cerebral palsy in a clinical setting.
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
- School of Physical Therapy, Faculty of Health Sciences, Western University, London, Ontario, Canada.
- Department of Health & Rehabilitation Sciences, Faculty of Health Sciences, Western University, London, Ontario, Canada.
ORCID-Profile: Caitlin Cassidy
Förderung
- Academic Medical Organization of Southwestern Ontario
Zitieren
APA
Cassidy, C., Wiener, J. C., Pratt, K., & Brunton, L. (2026). Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting. PM&R. https://doi.org/10.1002/pmrj.70135
Vancouver
Cassidy C, Wiener JC, Pratt K, Brunton L. Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting. PM&R. 2026. doi:10.1002/pmrj.70135
BibTeX
@article{Cassidy2026,
author = {Cassidy, Caitlin and Wiener, Joshua C and Pratt, Karen and Brunton, Laura},
title = {Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting},
journal = {PM&R},
year = {2026},
doi = {10.1002/pmrj.70135}
}
EUVIMED